Breaking News Instant updates and real-time market news.

EYPT

EyePoint

$7.78 /

-0.02 (-0.26%)

05:43
07/07/22
07/07
05:43
07/07/22
05:43

EyePoint initiated with a Buy at Chardan

Chardan analyst Daniil Gataulin initiated coverage of EyePoint Pharmaceuticals with a Buy rating and $21 price target. The company's Durasert technology is a micro-implant that can be injected intravitreally in an office setting and is "well-validated," Gataulin tells investors in a research note. The analys adds that vorolanib has a "well-established proof-of-concept" in wet age-related macular degeneration.

  • 21

    Jul

  • 17

    Nov

OTHER BREAKING NEWS FROM THE FLY

Earnings
Aramark reports Q3 adjusted EPS 25c, consensus 24c » 06:30
08/09/22
08/09
06:30
08/09/22
06:30
ARMK

Aramark

$35.27 /

+0.16 (+0.46%)

Reports Q3 revenue $4.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

ARMK Aramark
$35.27 /

+0.16 (+0.46%)

03/29/22 Deutsche Bank
Aramark initiated with a Hold at Deutsche Bank
03/11/22 BofA
Aramark reinstated with a Buy at BofA
12/10/21 Stifel
Aramark positioning for strategic transaction for Uniform business, says Stifel
12/09/21 Baird
Aramark 'raises the growth bar' with analyst day targets, says Baird
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

Periodicals
US solar industry facing disruptions with new import ban, WSJ reports » 06:29
08/09/22
08/09
06:29
08/09/22
06:29
CSIQ

Canadian Solar

$39.13 /

+0.44 (+1.14%)

, SPWR

SunPower

$24.05 /

-0.015 (-0.06%)

, FSLR

First Solar

$106.66 /

+4.78 (+4.69%)

, TSL

Trina Solar

/

+

, JASO

JA Solar

$7.50 /

+ (+0.00%)

, YGE

Yingli Green Energy

/

+

The U.S. solar industry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSIQ Canadian Solar
$39.13 /

+0.44 (+1.14%)

SPWR SunPower
$24.05 /

-0.015 (-0.06%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

CSIQ Canadian Solar
$39.13 /

+0.44 (+1.14%)

08/08/22 JPMorgan
Canadian Solar price target raised to $42 from $38 at JPMorgan
07/20/22 JPMorgan
Canadian Solar price target raised to $38 from $36 at JPMorgan
06/29/22 Roth Capital
Roth sees CBP requiring quartzite docs as 'major problem' for solar industry
03/28/22 Citi
Canadian Solar price target raised to $45 from $40 at Citi
SPWR SunPower
$24.05 /

-0.015 (-0.06%)

08/08/22 JPMorgan
SunPower price target raised to $25 from $20 at JPMorgan
08/04/22 Barclays
SunPower initiated with an Equal Weight at Barclays
07/22/22 Roth Capital
SunPower price target lowered to $18 from $20 at Roth Capital
07/20/22 JPMorgan
SunPower price target raised to $20 from $19 at JPMorgan
FSLR First Solar
$106.66 /

+4.78 (+4.69%)

08/08/22 JPMorgan
First Solar upgraded to Overweight from Neutral at JPMorgan
08/08/22 Guggenheim
First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act
08/08/22 Guggenheim
First Solar upgraded to Buy from Neutral at Guggenheim
08/05/22 Argus
First Solar price target raised to $123 from $104 at Argus
TSL Trina Solar
/

+

JASO JA Solar
$7.50 /

+ (+0.00%)

YGE Yingli Green Energy
/

+

CSIQ Canadian Solar
$39.13 /

+0.44 (+1.14%)

SPWR SunPower
$24.05 /

-0.015 (-0.06%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

CSIQ Canadian Solar
$39.13 /

+0.44 (+1.14%)

SPWR SunPower
$24.05 /

-0.015 (-0.06%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

TSL Trina Solar
/

+

JASO JA Solar
$7.50 /

+ (+0.00%)

YGE Yingli Green Energy
/

+

CSIQ Canadian Solar
$39.13 /

+0.44 (+1.14%)

SPWR SunPower
$24.05 /

-0.015 (-0.06%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

SPWR SunPower
$24.05 /

-0.015 (-0.06%)

FSLR First Solar
$106.66 /

+4.78 (+4.69%)

Downgrade
Baird downgrades Bed Bath & Beyond to sell after 86% two-day rally » 06:29
08/09/22
08/09
06:29
08/09/22
06:29
BBBY

Bed Bath & Beyond

$11.41 /

+3.26 (+40.00%)

Baird analyst Justin…

Baird analyst Justin Kleber downgraded Bed Bath & Beyond to Underperform from Neutral with an unchanged price target of $4. The stock closed Monday up 40% to $11.41. The shares have surged 148% since July 27, including 86% in the past two trading days, Kleber tells investors in a research note. The analyst says the rally has been "driven by non-fundamentally focused market participants." With market share losses accelerating and Bed Bath "burning cash," the stock's fundamental risk/reward looks unattractive, contends Kleber. He estimates the company would need to generate over $350M of EBITDA by fiscal 2025 to justify the stock's current $2.3B enterprise value. This is a "tall order given the current macro/sector backdrop," the analyst writes.

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$11.41 /

+3.26 (+40.00%)

BBBY Bed Bath & Beyond
$11.41 /

+3.26 (+40.00%)

05:56 Today Baird
Bed Bath & Beyond downgraded to Underperform from Neutral at Baird
08/08/22 Odeon Capital
Bed Bath & Beyond cut to Hold at Odeon Capital following doubling in a week
08/08/22 Odeon Capital
Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital
06/30/22 B. Riley
Bed Bath & Beyond price target lowered to $5 from $7 at B. Riley
BBBY Bed Bath & Beyond
$11.41 /

+3.26 (+40.00%)

BBBY Bed Bath & Beyond
$11.41 /

+3.26 (+40.00%)

BBBY Bed Bath & Beyond
$11.41 /

+3.26 (+40.00%)

BBBY Bed Bath & Beyond
$11.41 /

+3.26 (+40.00%)

Periodicals
Carlyle's CEO contract proposal was met with silence from board, WSJ reports » 06:29
08/09/22
08/09
06:29
08/09/22
06:29
CG

Carlyle Group

$35.30 /

-2.34 (-6.22%)

As Carlyle CEO Kewsong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

07/29/22 Evercore ISI
Carlyle Group upgraded to Outperform from In Line at Evercore ISI
07/13/22 Deutsche Bank
Carlyle Group price target lowered to $56 from $64 at Deutsche Bank
06/08/22 JMP Securities
Carlyle Group initiated with an Outperform at JMP Securities
05/19/22 Deutsche Bank
Carlyle Group price target lowered to $64 from $68 at Deutsche Bank
CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

  • 10
    Nov
CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

CG Carlyle Group
$35.30 /

-2.34 (-6.22%)

Recommendations
XPO Logistics price target raised to $80 from $70 at Raymond James » 06:26
08/09/22
08/09
06:26
08/09/22
06:26
XPO

XPO Logistics

$57.86 /

-2.02 (-3.37%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$57.86 /

-2.02 (-3.37%)

XPO XPO Logistics
$57.86 /

-2.02 (-3.37%)

08/08/22 Citi
XPO Logistics price target raised to $75 from $70 at Citi
07/15/22 Raymond James
XPO Logistics price target lowered to $70 from $90 at Raymond James
07/12/22 Evercore ISI
XPO Logistics price target lowered to $67 from $83 at Evercore ISI
07/12/22 JPMorgan
XPO Logistics price target lowered to $72 from $81 at JPMorgan
XPO XPO Logistics
$57.86 /

-2.02 (-3.37%)

XPO XPO Logistics
$57.86 /

-2.02 (-3.37%)

XPO XPO Logistics
$57.86 /

-2.02 (-3.37%)

Recommendations
Karuna Therapeutics price target raised to $261 from $160 at BofA » 06:25
08/09/22
08/09
06:25
08/09/22
06:25
KRTX

Karuna Therapeutics

$241.52 /

+101.41 (+72.38%)

BofA analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

08/08/22 Stifel
Cerevel Therapeutics price target raised to $54 from $50 at Stifel
08/08/22 Stifel
Karuna Therapeutics price target raised to $260 from $185 at Stifel
08/08/22 JMP Securities
Karuna Therapeutics price target raised to $315 from $190 at JMP Securities
08/08/22 Citi
Karuna Therapeutics price target raised to $280 from $162 at Citi
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

  • 10
    Aug
  • 10
    Nov
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

Recommendations
Aurinia Pharmaceuticals price target lowered to $26 from $30 at H.C. Wainwright » 06:24
08/09/22
08/09
06:24
08/09/22
06:24
AUPH

Aurinia Pharmaceuticals

$8.28 /

-0.075 (-0.90%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

05/05/22 Cantor Fitzgerald
Aurinia Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
05/04/22 H.C. Wainwright
Aurinia Pharmaceuticals price target lowered to $30 from $33 at H.C. Wainwright
04/28/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $22 from $27 at RBC Capital
03/01/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $27 from $31 at RBC Capital
AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

AUPH Aurinia Pharmaceuticals
$8.28 /

-0.075 (-0.90%)

Recommendations
Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright » 06:24
08/09/22
08/09
06:24
08/09/22
06:24
PLRX

Pliant Therapeutics

$18.95 /

+0.04 (+0.21%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

07/26/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald
07/20/22 SVB Securities
Pliant Therapeutics initiated with an Outperform at SVB Securities
07/11/22 Piper Sandler
Pliant Therapeutics price target raised to $40 from $27 at Piper Sandler
07/11/22 Cantor Fitzgerald
Pliant Therapeutics price target raised to $36 from $28 at Cantor Fitzgerald
PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

  • 13
    Jul
PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

PLRX Pliant Therapeutics
$18.95 /

+0.04 (+0.21%)

Syndicate
PennantPark Floating Rate 4M share Spot Secondary priced at $12.40 » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
PFLT

PennantPark Floating Rate

$13.21 /

+0.3 (+2.32%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFLT PennantPark Floating Rate
$13.21 /

+0.3 (+2.32%)

PFLT PennantPark Floating Rate
$13.21 /

+0.3 (+2.32%)

08/09/21 Ladenburg
PennantPark Floating Rate downgraded to Neutral at Ladenburg
08/09/21 Ladenburg
PennantPark Floating Rate downgraded to Neutral from Buy at Ladenburg
PFLT PennantPark Floating Rate
$13.21 /

+0.3 (+2.32%)

  • 09
    Aug
Recommendations
Acadia Pharmaceuticals price target raised to $25 from $20 at H.C. Wainwright » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
ACAD

Acadia Pharmaceuticals

$16.65 /

+0.225 (+1.37%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

05:40 Today Citi
Acadia Pharmaceuticals price target raised to $17 from $15 at Citi
08/08/22 Cowen
Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen
08/05/22 Citi
Acadia Pharmaceuticals downgraded to Neutral from Buy at Citi
06/22/22 Canaccord
Acadia Pharmaceuticals price target lowered to $20 from $31 at Canaccord
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

Recommendations
PubMatic price target lowered to $34 from $40 at JMP Securities » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
PUBM

PubMatic

$17.81 /

+0.365 (+2.09%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

08/04/22 Jefferies
PubMatic price target lowered to $20 from $23 at Jefferies
08/01/22 KeyBanc
PubMatic downgraded to Sector Weight from Overweight at KeyBanc
07/27/22 KeyBanc
Google's cookie phase-out delay not surprising, says KeyBanc
07/27/22 RBC Capital
Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

PUBM PubMatic
$17.81 /

+0.365 (+2.09%)

Hot Stocks
Village Farms announces Leli Holland been granted tenth cannabis license » 06:23
08/09/22
08/09
06:23
08/09/22
06:23
VFF

Village Farms

$3.13 /

-0.06 (-1.88%)

Village Farms announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

VFF Village Farms
$3.13 /

-0.06 (-1.88%)

05/11/22 Craig-Hallum
Village Farms price target lowered to $5 from $15 at Craig-Hallum
05/11/22 Raymond James
Village Farms downgraded to Outperform from Strong Buy at Raymond James
05/10/22 Alliance Global Partners
Village Farms price target lowered to $10 from $17 at Alliance Global Partners
03/03/22 Stifel
Village Farms downgraded to Hold from Buy at Stifel
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

Recommendations
uniQure selloff brings attractive entry point, says H.C. Wainwright » 06:21
08/09/22
08/09
06:21
08/09/22
06:21
QURE

uniQure

$18.60 /

-6.92 (-27.12%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

08/08/22 Chardan
uniQure price target lowered to $60 from $65 at Chardan
08/08/22 Truist
uniQure's high-dose HD data still on track for 1H23, says Truist
05/05/22 Stifel
uniQure price target lowered to $37 from $66 at Stifel
04/13/22 Truist
uniQure price target lowered to $51 from $90 at Truist
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

Earnings
Village Farms reports Q2 EPS (41c) vs. (13c) last year » 06:21
08/09/22
08/09
06:21
08/09/22
06:21
VFF

Village Farms

$3.13 /

-0.06 (-1.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

VFF Village Farms
$3.13 /

-0.06 (-1.88%)

05/11/22 Craig-Hallum
Village Farms price target lowered to $5 from $15 at Craig-Hallum
05/11/22 Raymond James
Village Farms downgraded to Outperform from Strong Buy at Raymond James
05/10/22 Alliance Global Partners
Village Farms price target lowered to $10 from $17 at Alliance Global Partners
03/03/22 Stifel
Village Farms downgraded to Hold from Buy at Stifel
VFF Village Farms
$3.13 /

-0.06 (-1.88%)

General news
European stock markets are narrowly mixed, » 06:20
08/09/22
08/09
06:20
08/09/22
06:20
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. productivity preview » 06:20
08/09/22
08/09
06:20
08/09/22
06:20
$ECON

Economic Data

/

+

U.S. productivity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
Myovant Sciences upgraded to Outperform from Market Perform at SVB Securities » 06:19
08/09/22
08/09
06:19
08/09/22
06:19
MYOV

Myovant Sciences

/

+

SVB Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
/

+

MYOV Myovant Sciences
/

+

06:11 Today SVB Securities
Myovant Sciences upgraded to Outperform from Market Perform at SVB Securities
04/13/22 Baird
Myovant Sciences price target lowered to $20 from $30 at Baird
09/09/21 SVB Leerink
SVB Leerink starts Myovant at Market Perform
09/09/21 SVB Leerink
Myovant Sciences initiated with a Market Perform at SVB Leerink
MYOV Myovant Sciences
/

+

MYOV Myovant Sciences
/

+

Recommendations
Precigen price target lowered to $6 from $10 at H.C. Wainwright » 06:19
08/09/22
08/09
06:19
08/09/22
06:19
PGEN

Precigen

$2.07 /

-0.01 (-0.48%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PGEN Precigen
$2.07 /

-0.01 (-0.48%)

PGEN Precigen
$2.07 /

-0.01 (-0.48%)

07/05/22 Stifel
Precigen subsidiary sale relieves convertible debt overhang, says Stifel
PGEN Precigen
$2.07 /

-0.01 (-0.48%)

Recommendations
SpringsWorks Therapeutics price target lowered to $94 from $95 at H.C. Wainwright » 06:18
08/09/22
08/09
06:18
08/09/22
06:18
SWTX

SpringsWorks Therapeutics

$39.68 /

+2.825 (+7.67%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

06/06/22 H.C. Wainwright
SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
05/27/22 Wedbush
SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush
05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

SWTX SpringsWorks Therapeutics
$39.68 /

+2.825 (+7.67%)

Hot Stocks
Huntsman to sell Textile Effects division to Archroma for $718M » 06:18
08/09/22
08/09
06:18
08/09/22
06:18
HUN

Huntsman

$29.26 /

+0.34 (+1.18%)

Huntsman announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUN Huntsman
$29.26 /

+0.34 (+1.18%)

HUN Huntsman
$29.26 /

+0.34 (+1.18%)

08/04/22 Citi
Huntsman price target lowered to $34 from $35 at Citi
08/03/22 Deutsche Bank
Huntsman price target lowered to $35 from $40 at Deutsche Bank
07/25/22 UBS
Huntsman downgraded to Neutral from Buy at UBS
06/22/22 Wells Fargo
Huntsman price target lowered to $35 from $42 at Wells Fargo
HUN Huntsman
$29.26 /

+0.34 (+1.18%)

HUN Huntsman
$29.26 /

+0.34 (+1.18%)

HUN Huntsman
$29.26 /

+0.34 (+1.18%)

Recommendations
Relay Therapeutics price target lowered to $46 from $47 at H.C. Wainwright » 06:18
08/09/22
08/09
06:18
08/09/22
06:18
RLAY

Relay Therapeutics

$19.85 /

+0.15 (+0.76%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLAY Relay Therapeutics
$19.85 /

+0.15 (+0.76%)

06/06/22 Jefferies
Relay Therapeutics initiated with an Underperform at Jefferies
05/10/22 H.C. Wainwright
Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright
05/09/22 JMP Securities
Relay Therapeutics price target lowered to $35 from $50 at JMP Securities
02/01/22 Berenberg
Relay Therapeutics initiated with a Buy at Berenberg
RLAY Relay Therapeutics
$19.85 /

+0.15 (+0.76%)

  • 13
    Oct
Upgrade
Inspirato upgraded to Overweight from Neutral at Cantor Fitzgerald » 06:17
08/09/22
08/09
06:17
08/09/22
06:17
ISPO

Inspirato

$4.93 /

-0.11 (-2.18%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

08/08/22 Piper Sandler
Inspirato price target lowered to $7 from $9 at Piper Sandler
07/22/22 Cantor Fitzgerald
Inspirato assumed with a Neutral at Cantor Fitzgerald
06/28/22 Stifel
Inspirato price target lowered to $6 from $7 at Stifel
06/14/22 Oppenheimer
Inspirato initiated with a Perform at Oppenheimer
ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

ISPO Inspirato
$4.93 /

-0.11 (-2.18%)

Initiation
Finch Therapeutics initiated with a Buy at H.C. Wainwright » 06:17
08/09/22
08/09
06:17
08/09/22
06:17
FNCH

Finch Therapeutics

$2.47 /

+0.22 (+9.78%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

04/04/22 Jefferies
Finch Therapeutics price target lowered to $17 from $29 at Jefferies
FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

FNCH Finch Therapeutics
$2.47 /

+0.22 (+9.78%)

Recommendations
Tyson Foods price target lowered to $90 from $99 at BMO Capital » 06:16
08/09/22
08/09
06:16
08/09/22
06:16
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
07/20/22 Cleveland Research
Tyson Foods downgraded to Neutral from Buy at Cleveland Research
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

Recommendations
Signify Health, CVS deal could be 'win-win,' says Deutsche Bank » 06:16
08/09/22
08/09
06:16
08/09/22
06:16
SGFY

Signify Health

$22.06 /

+2.195 (+11.05%)

, CVS

CVS Health

$102.00 /

-0.34 (-0.33%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

08/08/22 Cowen
Signify Health price target raised to $24 from $14 at Cowen
08/08/22 BofA
CVS deal for Signify would help with continued evolution, says BofA
08/04/22 Piper Sandler
Signify Health price target raised to $34 from $32 at Piper Sandler
07/28/22 RBC Capital
Signify Health initiated with a Sector Perform at RBC Capital
CVS CVS Health
$102.00 /

-0.34 (-0.33%)

08/08/22 BofA
CVS deal for Signify would help with continued evolution, says BofA
08/04/22 Evercore ISI
CVS Health removed from 'TAP Outperform' list at Evercore ISI
08/04/22 Deutsche Bank
CVS Health price target raised to $120 from $113 at Deutsche Bank
07/21/22 Stifel
Logical to see Oak Street, Cano as 'in play' after 1Life deal, says Stifel
SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

SGFY Signify Health
$22.06 /

+2.195 (+11.05%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

CVS CVS Health
$102.00 /

-0.34 (-0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.